Assay Details
Target Gene Details
Entrez Gene ID: | 80350 |
Gene Name: | lipoprotein(a) like 2, pseudogene |
Gene Aliases: |
APOA2, APOAL, APOARGC, apo(a)rg-C |
Location: |
Chr.6:160466555-160511124 on Build GRCh38 |
Assay Gene Location: | Within Intron 2 |
Gene Symbol | Transcript Accession | Exon Location | Assay Transcript Location | Protein ID |
---|---|---|---|---|
LPAL2 | NR_028092.1 | |||
NR_028093.1 | ||||
U19517.1 | AAA85692.1 | |||
U19518.1 | AAA85693.1 |
Target Copy Number Variation Details
DGV Version: |
Release date: 2016-05-15, GRCh GRCh38 |
Target Variation |
Location | CNV Subtype |
Genes |
---|---|---|---|
esv3611438 | Chr.6:160487993 - 160503876 on Build GRCh38 | Gain | LPAL2 |
nsv5566 | Chr.6:160484923 - 160518346 on Build GRCh38 | Insertion | LPAL2 |
esv35098 | Chr.6:160001557 - 160649838 on Build GRCh38 | Gain | SLC22A3 IGF2R LOC729603 SLC22A1 LPAL2 SLC22A2 AIRN LPA |
nsv818463 | Chr.6:160014537 - 160604515 on Build GRCh38 | Gain | SLC22A3 IGF2R LOC729603 SLC22A1 LPAL2 SLC22A2 LPA |
esv6519 | Chr.6:160456601 - 160535561 on Build GRCh38 | Loss | LPAL2 LPA |
esv3611436 | Chr.6:160456712 - 160535559 on Build GRCh38 | Gain | LPAL2 LPA |
esv2733055 | Chr.6:160457077 - 160668796 on Build GRCh38 | Deletion | LPAL2 LPA |
nsv1026543 | Chr.6:160306836 - 161585804 on Build GRCh38 | Gain | MAP3K4 AGPAT4 SLC22A3 LOC105378098 PARK2 PLG LPAL2 AGPAT4-IT1 LPA |
esv2759484 | Chr.6:159951212 - 160813633 on Build GRCh38 | Gain+Loss | SLC22A3 IGF2R LOC729603 SLC22A1 PLG LPAL2 SLC22A2 AIRN LPA |
esv8214 | Chr.6:160494926 - 160499103 on Build GRCh38 | Loss | LPAL2 |
nsv969463 | Chr.6:160493093 - 160497203 on Build GRCh38 | Duplication | LPAL2 |
nsv525990 | Chr.6:160482590 - 160549931 on Build GRCh38 | Loss | LPAL2 LPA |
More Information
Additional Information:
For this assay, SNP(s) [rs75515602] are located under a primer or probe sequence. To help evaluate the possible impact of a given SNP on your experiment, please refer to the 1000 Genomes and NCBI dbSNP databases. A higher minor allele frequency in your study population represents a higher risk to assay performance.
Set Membership: |
Intragenic Intronic Non-exonic DGV Variation |